Previous Article | Next Article 
Journal of Virology, July 2001, p. 6337-6347, Vol. 75, No. 14
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.14.6337-6347.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
A Ty1 Reverse Transcriptase Active-Site Aspartate
Mutation Blocks Transposition but Not Polymerization
Ozcan
Uzun1 and
Abram
Gabriel2,*
Graduate Program in Biochemistry and
Molecular Biology, Robert Wood Johnson Medical School, University
of Medicine and Dentistry of New Jersey,1 and
Department of Molecular Biology and Biochemistry, Rutgers
University,2 Piscataway, New Jersey 08854
Received 28 December 2000/Accepted 12 April 2001
 |
ABSTRACT |
Reverse transcriptases (RTs) are found in a wide variety of mobile
genetic elements including viruses, retrotransposons, and infectious
organellar introns. An invariant triad of aspartates is thought to be
required for the catalytic function of RTs. We generated RT mutants in
the yeast retrotransposon Ty1, changing each of these active-site
aspartates to asparagine or glutamate. All but one of the mutants
lacked detectable polymerase activity. The novel exception,
D211N, retained near wild-type in vitro polymerase activity
within virus-like particles but failed to carry out in vivo
transposition. For this mutant, minus-strand synthesis is impaired and
formation of the plus-strand strong-stop intermediate is eliminated.
Intragenic second-site suppressor mutations of the transposition defect
map to the RNase H domain of the enzyme. Our results demonstrate that
one of the three active-site aspartates in a retrotransposon RT is not
catalytically critical. This implies a basic difference in the
polymerase active-site geometry of Ty1 and human immunodeficiency virus
RT and shows that subtle mutations in one domain can cause dramatic
functional effects on a distant domain of the same enzyme.
 |
INTRODUCTION |
Reverse transcriptase (RT), the DNA
polymerase that copies RNA templates into DNA, has been identified in
numerous biological niches. While vertebrate retrovirus RTs, and in
particular human immunodeficiency virus (HIV-1) RT, have been
intensively studied (14), families of endogenous
RT-encoding retrotransposons are ubiquitous among eukaryotes. Based on
the amino acid sequence of their RTs, retrotransposons and retroviruses
have been placed into a superfamily of RT-containing genetic elements,
where structurally related elements identified in many species cluster
with one another (21, 76). Aside from retrotransposons,
the superfamily includes classes of RTs found in other viruses
(72), bacteria (36), self-splicing introns
(78), mitochondrial plasmids (73), and most
recently the catalytic component of the nearly universal enzyme
telomerase (49). Based on these phylogenetic
considerations, RT is thought to be an ancient enzyme that evolved from
a primordial RNA-dependent RNA polymerase (25, 55).
Saccharomyces cerevisiae is home to five families of
multicopy long terminal repeat (LTR)-containing endogenous
retrotransposons, of which Ty1 is the most abundant (40).
Studies of Ty1 have demonstrated its essential structural and
functional relatedness to vertebrate retroviruses (reviewed in
reference 14). The complete element contains two
overlapping open reading frames (ORFs), termed TYA
(analogous to retroviral GAG) and TYB (analogous
to retroviral POL), and is flanked by LTRs made up of
distinct U3, R, and U5 regions. Within the second ORF, separate
protease, integrase (IN), and RT/RNase H domains have been identified.
Ty1 DNA is present on chromosomes and is transcribed and processed
using regulatory sequences in its LTR. This RNA is translated and also
serves as the genomic RNA for reverse transcription. Ty1 translation
products assemble, along with Ty1 RNA and host tRNA, into cytoplasmic
virus-like particles (VLPs) in which replication occurs.
The key to replication of both retroviruses and retrotransposons is the
RT enzyme, which contains spatially separated amino-terminal polymerase
and carboxy-terminal RNase H domains. While the polymerase carries out
template- and primer-directed DNA polymerization, using either RNA or
DNA as the primer and template, the RNase H degrades RNA within RNA-DNA
duplexes (14). Within the context of these basic
functions, the two domains of the enzyme are required to carry out
specific, sequential, and interrelated reactions in order for the
genomic RNA to be successfully copied into an integratable
double-stranded cDNA. For example, Ty1 replication is initiated by the
polymerase domain of RT copying the 5' end of Ty1 RNA, using initiator
methionine tRNA (IMT) as the minus-strand primer. While polymerase
copies the RNA, the associated RNase H activity is presumed to follow
and degrade the RNA in the resulting RNA-DNA hybrid. The terminated
product is termed the minus-strand strong-stop intermediate (msss). For
copying to continue, the RT and its primer end must undergo an RNase
H-dependent translocation, termed strand transfer. After transfer,
minus-strand synthesis progresses along the RNA template. A short
region of RNA just upstream of the 3' U3, referred to as the polypurine
tract (PPT), is specifically spared from RNase H cleavage and is then
used by the polymerase as the primer to generate the plus-strand
strong-stop intermediate (psss). Subsequent plus-strand transfer allows
continued synthesis of both strands. The final product is a
double-stranded cDNA which can insert into a new genomic location.
Phylogenetic studies comparing the sequences of RTs from many sources
have noted a triad of conserved aspartic acid (D) residues (21,
60, 76). Two of these Ds are part of the YXDD box in motif C,
which serves as a signature for RTs, while the other D is ~75 to 100 amino acids amino terminal to this box in a region referred to as motif
A (60) (the equivalent residues are D110, D185, and D186 for HIV-1 RT and
D129, D210, and D211 for Ty1). The
near invariability of these residues, their alignment with catalytic
aspartates from other polymerases (17), and the finding that replacement of any one of these Ds in HIV-1 RT results in the loss
of both in vitro RT activity and infectivity (11, 39, 44, 45,
47) have led to the conclusion that these are three critical
catalytic residues. Further, multiple crystal structures of the HIV-1
RT (35, 38, 41) and a portion of the Moloney murine
leukemia virus RT (33) all place these three residues within the active-site pocket of the enzyme. Within the wider range of
sequenced retroelements, however, a few exceptions have been noted. A
gene encoding an RT-like protein in the mitochondrial genome of
Chlamydomonas reinhardtii has the YXDD box sequence YADN
(8). Tas, an Ascaris lumbricoides
retrotransposon, contains the corresponding sequence YVDN
(27), as do several families of LTR-containing
retrotransposons recently identified through the Caenorhabditis
elegans sequencing project (9). In none of these
cases has the nonstandard RT-like ORF been shown to have biochemical
activity, nor have any of these exceptional elements been shown to be
transpositionally active. Their existence, however, suggests the
possibility that the second aspartate in the YXDD box is not
catalytically essential.
We have used yeast Ty1 to look directly at whether all three of the
conserved aspartate residues are essential for retrotransposon RT
function. We find that unlike all other substitutions examined, substitution of asparagine for aspartate at position 211, the second D
in the YXDD box, does not obviously affect the exogenous polymerase
activity of the enzyme. However, the mutant Ty1 element is completely
incapable of carrying out transposition. Intragenic second-site
suppressors mapping to the RNase H domain can restore transposition
competence. Our results provide biochemical and genetic evidence that
the second aspartate side chain in the YXDD box of retrotransposon RT
polymerases is not essential for catalyzing the polymerization reaction
but does play critical roles in the replication process, possibly by
coordinating RNase H and polymerase activities.
 |
MATERIALS AND METHODS |
Strains and culture conditions.
Yeast strain YH50
(MAT
ho spt3-202 ura3-167 trp1
1 leu2-3 his3
200)
(20) or the isogenic rad52::LEU2 strain AGY49
(71) were used for genetic assays, while strain YH51
(MATa ura3 his 4-539 lys2-801 spt-202)
(29) was used for preparation of VLPs. All strains are
spt3, which eliminates endogenous transposition and its
potential for complementation of mutant Ty1 elements in trans or background Ty1 RT activity within VLPs
(6). Standard synthetic complete (SC) medium with omission
of different combinations of amino acids, yeast-peptone-dextrose (YPD)
medium and SC medium containing 5-fluoroorotic acid (SC+5FOA) were
prepared and used as previously described (5, 66).
Plasmid constructions.
Site-directed mutants were
constructed by the method of Kunkel (42). All sequence
changes were confirmed.
(i) Mutant versions of pJEF724.
The 1,120-bp
KpnI-HindIII fragment from the
URA3-marked, 2µm-based, GAL1-driven Ty1-H3
plasmid pJEF724 (4) was ligated with similarly cut M13mp18
replicative-form phage. Recombinant plaques produced single-stranded
phage, which was annealed with mutagenic primer AG19 (5' CAA TAC
CAT ATT ATC TAC GAA TAA 3') or AG20 (5' CAA TAC CAT TTC ATC
TAC GAA TAA 3') to generate asparagine (D211N) or
glutamate (D211E) substitutions, respectively (Ty1-H3, position 4577). The 1,120-bp KpnI-HindIII
fragment from mutant replicative-form phages was subcloned back into
similarly digested pJEF724. Additional active-site mutants were
obtained by the same procedures using mutagenic primers AG37 (5'
TTT TTG CTA AAG AGC ACC ATG TCC TCT ACG AAT AA 3') and AG38
(5' CAA TAC CAT GTC GTT AAC GAA TAA ACA 3') to generate the
D210E and D210N substitutions (Ty1-H3 position
4574) and mutagenic primers RAG81 (5' CGA AGA TAT CTC TAA TTG TG
3') and RAG82 (5' TGC CGA AGA AAT ATT TAA TTG TG 3')
to generate the D129E and D129N
substitutions (Ty1-H3 position 4357).
(ii) Mutant versions of pX3.
Each of the six pJEF724
mutations was subcloned into pX3 (a derivative of pJEF724 with a
TRP1 marker in the Ty1 3' untranslated region
[7]) by ligating the mutant
KpnI-HindIII fragment with the largest
KpnI-HindIII fragment of pX3, digesting the
resulting plasmid with HindIII, ligating it with the
1,093-bp TRP1-containing HindIII fragment
from pX3, and subsequently identifying the correctly oriented insert.
(iii) Mutant versions of pGTy1mhis3AI.
Mutant
versions of pGTy1mhis3AI were made in several steps. First,
pGTyCla (AGE565), which is equivalent to pJEF724 except for the
presence of a unique ClaI site in the Ty1 3' untranslated region (Ty1-H3 position 5561), was constructed by digesting plasmid pBJC8 (15) with ClaI and self-ligating the
large fragment. Second, the 4.4-kb
XhoI-HindIII Ty1-containing fragment of
AGE565 was subcloned into pBSIIKS(+) and the resulting phagemid was
used to introduce a new MluI site at Ty1-H3 position 3219 with primer RAG205 (5' GTT TTA GAA ACG CGT TTC GAA T
3') (MluI site underlined). Third, the
MluI-containing phagemid (AGE1495) was digested with BstEII and HindIII and the resulting 2.8-kb
Ty1 fragment was ligated to similarly digested AGE565 to generate
plasmid AGE1542. Fourth, AGE1542 was linearized at its unique
ClaI site and ligated to the 990-bp
his3AI-containing fragment obtained by digesting BJC267 (15) with ClaI. Finally, the resulting plasmid
with the correct orientation of his3AI was partially
digested with ClaI and the downstream ClaI site
was filled in with Klenow polymerase and then religated to generate
AGE1589. The D211N version of pGTy1mhis3AI (AGE1603) contains both the D211N mutation and a new
adjacent BstBI site. Both were engineered by site-directed
mutagenesis of AGE1495, using RAG 204 (5' ATT TAG ATT TTT
CGA AAA CAA TAC CAT ATT ATC TAC GAA T 3') (the new
BstBI site underlined). The resulting phagemid (AGE1532) was
digested with BstEII and HindIII and ligated
to similarly digested AGE565 to generate AGE1598. AGE1598 was digested
with XhoI and ClaI, and the 5328-bp
Ty1-containing fragment was ligated to the similarly digested AGE1589.
(iv) pGTy1mhis3AI
KpnI.
pGTy1mhis3AI
KpnI (AGE1627) was constructed by
digesting AGE1589 with KpnI and self-ligating the largest
fragment. This procedure eliminates a 2,600-bp internal fragment of the
plasmid containing a portion of IN, the entire RT domain and a portion
of the his3AI gene.
(v) Second-site suppressor mutations.
Second-site suppressor
mutations were introduced into both wild-type (WT) and
D211N Ty1 plasmids. First, the 1,413-bp
HindIII-BamHI fragment from pJEF724 was
ligated to similarly digested pBSIIKS(+) to create AGE1038. Then
AGE1038 was mutagenized with oligonucleotides RAG567 (5' CAG TAA
GTA AGC CGC GGA TAA TTG GTT CTT GTT AAG 3'), RAG568 (5' CTG
ATA CTT CAT CTC TGA GAC CCA TTG CCT TTG 3'), and RAG565 (5'
CCT GAT ACT TCA TCA CGA AGT GAC ATT GCC TTT G 3') to introduce
the K463R, R495G, and R495S
substitutions, respectively (Ty1-H3 coordinates 5332, 5434, and 5434).
In each case, the resulting mutagenized phagemid was digested at a
unique BglII site in the Ty1 3' untranslated region, filled
in with Klenow polymerase, and religated to generate a new, unique
ClaI site. The resulting phagemids were transformed into a
Dam methyltransferase-defective Escherichia coli strain,
repurified, and digested with HindIII and
ClaI. The 939-bp Ty-containing fragments were ligated to
similarly digested D211-containing AGE565 vectors or
to similarly digested D211N- containing AGE1598
vectors. Finally, each of the six resulting plasmids was digested with
XhoI and ClaI and the 5,328-bp Ty1-containing fragment was ligated to the similarly digested AGE1589 vector to
generate AGE1904 (K463R,), AGE1907 (R495G),
AGE1906 (R495S), AGE1898
(D211N+K463R), AGE1902
(D211N+R495G), and AGE1901
(D211N+R495S) respectively.
(vi) D468S RNase H mutant plasmids.
The
construction of the D468S RNase H mutant plasmids (AGE1160
without his3AI and AGE1455 with his3AI,
corresponding to Ty1-H3 position 5347), was similar to the procedure
described above but will be presented in detail elsewhere (E. Mules and
A. Gabriel, unpublished data).
Qualitative transposition assay.
Patches from single
colonies containing various pGTy1mhis3AI plasmids were grown
at 30°C on agar plates containing SC medium lacking uracil plus 2%
glucose (SC-Ura+GLU), replica plated to SC medium lacking uracil plus
2% galactose (SC-Ura+GAL), incubated at 22°C for 5 days, replica
plated to SC medium lacking uracil and histidine plus 2% glucose
(SC-Ura-His+GLU), and observed after 3 days at 30°C.
Determination of transposition frequency.
For initial tests
of transposition (see Table 1), yeast strain YH50 containing various
mutant versions of pX3 was grown at 30°C as patches on SC-Ura+GLU
plates, replica plated to SC-Ura+GAL plates, incubated at 22°C for 5 days, then sequentially replica plated at 30°C to SC-Ura+GLU, YPD,
and SC+FOA plates. The cells were scraped from the SC+FOA plates into
sterile water, and various dilutions were plated on SC+FOA and
SC+FOA-Trp and subsequently counted.
Determination of transposition rate.
Ten independent
cultures of each strain containing various pGTy1mhis3AI
plasmids were grown for 2 days in liquid SC-Ura+raffinose medium,
diluted to ~500 cells per ml of SC-Ura+GAL, and incubated at 22°C
until saturation. Dilutions were plated on both SC-Ura+GLU and
SC-Ura-His+GLU plates. The frequency of transposition was calculated
for each culture by dividing the number of colonies per milliliter of
culture growing on SC-Ura-His plates by the number of colonies per
milliliter growing on SC-Ura plates. The median frequency for each
construct was found, and the transposition rate per cell per division
was calculated by the method of Drake (23).
Genetic screen for second-site suppressors.
Random mutations
were introduced into the D211N version of the Ty1 RT region
by PCR amplification (77) of a ~3.55-kb segment of
Ty1mhis3AI, using primers RAG34 (5' CAT ATC ATT CGT TCA
TTG CGT 3') (Ty1-H3 positions 3041 to 3061) and RAG450 (5'
TAC CAC CCA TAA TGT AAT AGA TC 3') (Ty1-H3 positions 5562 to
5584) with AGE1603 as the template. The PCR conditions used are
available on request. PCR products were mixed with equimolar amounts of KpnI-linearized pGTy1m his3AI
Kpn
(AGE1627) and cotransformed into competent yeast strain YH50 using the
high-efficiency TRAFO transformation method (R. Agatep, R. D. Kirkpatrick, D. L. Parchaliuk, R. A. Woods, and R. D. Gietz, Technical
Tips Online; http://tto.trends.com). Gap-repaired plasmids were
selected by growth on SC-Ura+GLU plates. In control experiments, we
found a 19:1 ratio of gap repair to end joining. Since AGE1627 lacks
the entire RT domain, its recircularization and transposition
competence depends on recombination either with the PCR product or with
an intact genomic Ty1 element. A total of 8,500 colonies from among
those capable of growth on SC-Ura+GLU plates were patched onto fresh
SC-Ura+GLU plates, which then served as masters for duplicate replica
plating onto SC-Ura+GAL. Replicas were grown at 22°C for 5 days,
replica plated to SC-His+GLU, and inspected after 3 days at 30°C.
Patches with lawns of growth on SC-His+GLU or inconsistencies between
the duplicates were ignored. A total of 101 patches with multiple
papillae were further analyzed. In each case a His+
Ura+ colony was purified, the yeast plasmid was shuttled
into E. coli (34), and the purified plasmid was
digested with MluI and BstBI to screen for
candidates that had not recombined with genomic Ty1 elements and had
consequently lost these engineered restriction sites. The RT domains of
six candidate plasmids which retained these restriction sites were
sequenced to confirm the D211N mutation and to identify
suppressor mutations. For each identified suppressor mutation,
site-directed mutagenesis was used to recreate the same substitution in
a native version of plasmid AGE1603 and confirm its ability to suppress
the D211N transposition defect.
VLP and nucleic acid preparation.
Ty1 VLPs were partially
purified through sequential sucrose gradients and concentrated as
previously described (12, 29, 53). Either these were used
directly or nucleic acids were extracted by proteinase digestion (50 µg of proteinase K per ml, 25 mM EDTA [pH 8.0], 0.5% sodium
dodecyl sulfate SDS) at 50°C for 1 h, followed by
phenol-chloroform extraction and ethanol precipitation. The total
protein concentration of VLP fractions was determined by the Bradford method.
Exogenous polymerization reactions.
Partially purified VLPs
were used to perform exogenous RT reactions, using either
poly(rC)-oligo(dG) as the template and primer as previously described
(24, 29, 31) or using 10 µg of activated calf thymus DNA
(Sigma) per ml as the random primer and template under the same
reaction conditions as for homopolymers, along with 10 µM each
unlabeled nucleotide and 100 nM labeled nucleotide.
Endogenous polymerization reactions.
VLPs were incubated
with all four nucleotides plus [
-32P]dATP at room
temperature for 90 min, as previously described (13); D. Voytas, personal communication). Each reaction mixture was divided
between two tubes; one tube was incubated with 0.325 N NaOH at 55°C
for 1 h and then 0.325 N HCl was added. Nucleic acids from both
tubes were then extracted as above, and resuspended reaction products
were separated on an 8% denaturing polyacrylamide gel.
Reiterative primer extension analysis.
To detect Ty1
replication intermediates, reiterative primer extension was carried out
with 5'-end-labeled strand-specific oligonucleotide primers. VLPs (see
Fig. 4A) or nucleic acids extracted from VLPs (see Fig. 4B through E)
were digested with 0.1 mg of RNase A per ml at 37°C for 10 min and
then incubated with labeled primers, using standard PCR buffers in a
20-µl volume, along with 2 U of Taq polymerase, 200 nM
labeled primer, and 200 µM each deoxynucleoside triphosphate (dNTP).
The PCR program was 30 cycles of 95°C for 30 s, 53°C for 2 min, and 72°C for 3 min. The extension products were separated on an
8% denaturing polyacrylamide gel, dried, and then analyzed by
phosphorimaging. Band intensities were quantified using Image-Quant
software. The primers used were RAG646 (5' GGA GAA CTT CTA GTA TAT
TCT GTA TAC C 3') (Ty1-H3 positions 243 to 270 or 5827 to 5854, and primer A in Fig. 4), RAG647 (5' GTG GAA GCT GAA ACG CAA GG 3')
(Ty1-H3 positions 113 to 132 or 5697 to 5716, and primer B in
Fig. 4), RAG743 (5' CTA TTA ACT AAC AAA TGG ATT CAT TAG 3')
(Ty1-H3 positions 5543 to 5562, and primer C in Fig. 4), RAG266
(5' CGA GAC CAA GAA GAA CAT TG 3') (Ty1-H3 positions 5475 to
5494, and primer D in Fig. 4), and RAG322 (5' AGA ATT GGG TGA ATG
TTG AG 3') (Ty1-H3 positions 332 to 313 or 5915 to 5897, and
primer E in Fig. 4).
For direct quantitative comparisons of specific replication
intermediates in different VLP preps (see Fig. 4 A and Table 3), the
volume of VLPs added to the primer extension analysis mixture was
normalized to equal amounts of Ty1 RT protein, based on Western blot
analysis. To compare different VLP preparations for the relative amounts of strand-transferred product, a 68-mer oligonucleotide complementary to both primers A and B (RAG822 [5' TAT GCA ATG CGT
CGA GCT CGA GGG TAT ACA GAA TAT ACT AGA AGT TCT CCT TGC GTT TCA GCT TCC
AC 3']) was added to each primer extension reaction mixture at
0.4 nM to serve as an internal control and to normalize results from
different reactions.
Immunoblot analysis.
Multiple dilutions of VLPs from
different sources were denatured and separated through a 10%
polyacrylamide-1% SDS denaturing gel, transferred to nitrocellulose
membranes, and incubated with polyclonal antiserum TyB8, raised against
a fusion protein from the Ty1 RT domain (32), to compare
Ty1 RT mutants. Antibody detection was carried out by enhanced
chemiluminescence as specified by the manufacturer (Amersham).
 |
RESULTS |
An active-site mutant that can polymerize but not transpose.
We generated a series of site-directed mutant versions of the
galactose-inducible, plasmid-based Ty1-H3 element, in which each of the
three invariant RT active-site aspartates was replaced with either
asparagine or glutamate. We transformed these constructs into yeast,
induced VLP formation, and collected VLPs for analysis of Ty1 RT
function. VLPs made from WT or mutant Ty1 elements all contained
similar levels of a ~60-kDa Ty1 RT protein (Table
1), indicating that these substitutions
affect neither the apparent size nor the stability of the protein. We
expected the mutants to all be devoid of polymerase activity. However,
when each VLP preparation was tested for in vitro polymerase activity,
using a standard homopolymer primer-template, we found that the
D211N substitution mutant retained near-WT levels of
polymerase activity (Table 1; also see Table 3). We confirmed this
unexpected result by rescuing the plasmid from yeast back into E. coli and sequencing the RT region to show that the site had not
reverted. Further, we recreated the substitution and obtained similar
results with VLPs generated from several independent plasmids. This
indicated that the D211N Ty1 RT mutant retained significant
polymerase activity using an exogenous DNA-RNA homopolymer. Since the
homopolymer primer-template is an unnatural substrate, we also examined
a random substrate, i.e., activated calf thymus DNA. The WT and D211N mutant enzymes were both able to incorporate dNTPs
into this primer-template (Table 1), while the D211E mutant
enzyme was not. Thus, only the D211N mutant is capable of
exogenous DNA polymerization, utilizing either a DNA or RNA template.
Finally, we asked whether a Ty1 element containing an active-site
aspartate mutation is still able to transpose. As shown in Table 1,
neither the D211N mutant nor any of the other active-site
mutants appeared competent for transposition in a standard
plasmid-based transposition assay (7).
To examine the transposition defect of the D
211N mutant in
greater detail, we next utilized the "
HIS3-artificial
intron" (i.e.,
his3AI) assay for cDNA formation
(
16). In this assay, an antisense
HIS3 gene in
the Ty1 3' untranslated region of a p
GALTy1 plasmid
contains
an artificial intron (AI) inserted in the antisense orientation
relative to
HIS3. The insertion makes the
his3AI
gene nonfunctional.
The AI can only be spliced out of the Ty1 RNA. If
this spliced
mRNA is reverse transcribed and the resulting cDNA is
inserted
back into the genome, by either transposition or
recombination,
a functional
HIS3 gene will be created,
resulting in histidine
prototrophy. Using this system, expression of a
wild-type p
GALTy1m
his3AI
plasmid leads to high
levels of histidine prototrophy (Fig.
1A)
while the D
211N mutant version is only rarely associated
with
histidine prototrophy (Fig.
1B). Quantitatively, the frequency
of
histidine prototrophy for the D
211N mutant, in a
recombination-proficient
strain, is ~2,000-fold lower than that of WT
Ty1 (data not shown).
Histidine prototrophy can result from either
transposition or
cDNA recombination (
65). We can
distinguish between these two
mechanisms by inducing Ty1 expression in
a recombination-deficient
rad52 yeast strain, since
recombination is
RAD52 dependent while
transposition is
RAD52 independent. We found that in a
rad52
strain
WT Ty1 could still generate histidine prototrophs but the
D
211N
mutant could not (Fig.
1G and H; Table
2). This indicates that
the rare
prototrophs observed for the D
211N mutant in the
RAD52 strain result from one or more recombinational
process.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 1.
Qualitative analysis of transposition and recombination
using a HIS3 marker gene. Yeast colonies are shown
growing on SC Ura His+GLU plates. Isogenic RAD52 (YH50)
and rad52 (AGY49) yeast strains were transformed with
plasmids AGE1589 (A and G), AGE1603 (B and H), AGE1902 (C and I), AGE
1901 (D and J), AGE1898 (E and K), or AGE1455 (F and L) and induced to
undergo Ty1 replication before being replica plated to a medium lacking
histidine.
|
|
To examine the basis for the rare histidine prototrophs in
RAD52 strains carrying the D
211N mutant Ty1
element, we isolated
54 individual His
+ colonies and
rescued the Ty1-containing plasmid back into
E. coli. By
restriction digestion analysis of the recovered plasmids,
we found that
31 (55%) had lost the two restriction sites (
MluI
and
BstBI) that had been engineered into the mutant plasmid to
distinguish it from endogenous Ty1 elements (Fig.
2A and data
not shown). The loss of these
sites most probably represents gene
conversion of the plasmid Ty1 by a
genomic Ty1 element, resulting
in replacement of the mutant asparagine
codon with the WT aspartate
codon and restoration of WT RT function
(
51). The remaining
23 plasmids (45%) retained the
distinguishing restriction sites
and presumably the D
211N
mutation. In these cells, the mutant
enzyme probably carried out
sufficient reverse transcription to
generate cDNA, which could
recombine with homologous plasmid or
chromosomal sequences (
18,
19). To test this, we replica plated
His
+ colonies
to SC+FOA

His plates. On this medium, absence of growth
implies that
histidine prototrophy is linked to the
URA3-containing
plasmid, i.e., the
HIS3 cDNA recombined with the
his3AI segment
on the plasmid. We found this linkage for 16 of the 23 events,
while
HIS3 was chromosomal in only 7 of 23 events. Thus, despite
its near-normal levels of exogenous polymerase
activity, the D
211N
mutant is incapable of transposition
and even its ability to generate
HIS3 cDNAs, which can
function in homologous recombination, is
greatly reduced.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 2.
Observation of psss and msss intermediates. Endogenously
labeled replication intermediates extracted from VLPs derived from WT,
the D468S RNase H active-site mutant, or the
D211N polymerase mutant versions of Ty1 were either run
directly on a denaturing polyacrylamide gel (lanes 1, 3, and 5) or
pretreated with alkali to hydrolyze RNA. The expected sizes of the msss
intermediate, with and without attached tRNA, and the psss intermediate
are shown to the right of the lanes.
|
|
The D211N mutant has endogenous polymerase
activity.
Since the D211N mutant can polymerize
using an exogenous template but cannot transpose, we next tested
endogenous polymerase activity by examining labeled intermediates of
Ty1 replication. We performed endogenous RT reactions, incubating VLPs
derived from WT or D211N mutant Ty1 elements with
[
-32P]dATP in the presence of all four nucleotides,
then extracted nucleic acids from the VLPs and separated them on
polyacrylamide gels. As a control, we also tested VLPs from a Ty1
element that contained a site-directed mutation in one of the presumed
active-site aspartates within the RNase H domain (D468S).
As shown autoradiographically, a discrete labeled product was observed
at ~170 nucleotides (nt) for WT, the D468S RNase H
mutant, and the D211N mutant (Fig. 2, lanes 1, 3, and 5).
This is the size expected for the msss intermediate (13).
To confirm this supposition, we treated nucleic acids derived from
endogenously labeled VLPs with alkali to hydrolyze the RNA components
of the labeled products. In each case the ~170-nt product disappeared
and an ~94-nt product appeared, as would be predicted if the IMT had
been degraded, leaving only the labeled cDNA portion (lanes 2, 4, and
6). The D211N mutant RT is therefore capable of endogenous
polymerization. It should be noted, however, that the D211N
mutant RT generates a much smaller amount of endogenous product than
does the WT or the D468S mutant per unit of VLP (Table 3). The three pairs of lanes shown in
Fig. 2 represent different exposures and are not directly comparable.
In the WT lanes, a prominent alkali stable band is present at ~334
nt, the size expected for the psss intermediate (Fig.
2,
lanes 1 and
2). Similar-size VLP-associated nucleic acids have
been previously
noted and attributed to psss (
54,
61). The
band is absent
from in vivo nucleic acids derived from the RNase
H mutant VLPs (lanes
3 and 4). This is expected, since RNase H
cleavage generates the PPT,
which is required to prime plus-strand
synthesis. The absence of this
band in nucleic acids derived from
the D
211N mutant (lanes
5 and 6) is not obviously explained but
does indicate that this mutant
is incapable of carrying out some
replication step beyond msss
synthesis, that is required for subsequent
psss
synthesis.
Generation of intragenic second-site suppressors of the
D211N transposition defect.
The finding
that the D211N mutant is incompetent for transposition
suggests that this subtle mutation creates one or more crucial defects
in the transposition process that are unrelated to its basic ability to
polymerize. To gain insights into the nature of these potential
defects, we used the his3AI marker system to carry out a
genetic screen for intragenic second-site suppressor mutations that
would allow the D211N RT mutant to overcome its transposition defect. As shown in Fig.
3A, we PCR amplified a 3,548-bp portion
of the Ty1mhis3AI plasmid, using the D211N
mutant version as the PCR template, to randomly generate one or two
mutations per PCR product. The PCR fragments were cotransformed into a
recombination-proficient yeast strain along with the linearized
URA3 marked plasmid pGTymhis3AI
KpnI (Fig. 3B). This plasmid lacks the entire RT domain and a portion of the
his3AI marker but retains ~500 bp of flanking homology to
the PCR product. By selecting for uracil prototrophy after transformation, we enriched the population for plasmids which have been
"gap repaired" by recombination with the PCR product. Colonies that
could grow on glucose plates lacking uracil were patched and induced to
express Ty1 by replica plating to SC
Ura+GAL. Patches were
subsequently replica plated onto glucose medium lacking histidine to
select for cells which had become histidine prototrophs, signifying
that they had regained the ability to synthesize cDNAs (see Materials
and Methods for further experimental details).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Important landmarks on the modified Ty1 element and
scheme for generating intragenic second-site suppressors via gap
repair. (A) Scale drawing of the his3AI marked Ty1-H3
element, showing the position of the D211N mutation, and
positions of restriction sites (MluI and BstBI)
engineered into the construct to distinguish it from endogenous Ty1
elements or used to create the gapped plasmid (KpnI). P1
(RAG34) and P2 (RAG450) refer to the plus- and minus-strand primers,
respectively, used to generate a randomly mutagenized 3,548-bp PCR
product spanning the carboxy-terminal half of the TyB ORF. (B) Plasmid
AGE1627 was linearized with KpnI and cotransformed with the
randomly mutagenized PCR fragment into the recombination-proficient
yeast strain YH50 to repair the gap and generate a circular plasmid.
|
|
By screening 8,500 cotransformants, we obtained 6 candidates with
elevated levels of histidine prototrophy in the presence
of the
D
211N mutation. We sequenced the entire RT domain of each
of these candidates and observed three classes of suppressor mutations.
The first class, obtained independently four times, consisted
of a
R
495G substitution (Fig.
1C). The second class, obtained
once, consisted of a K
463R substitution (Fig.
1E). Finally,
a
plasmid with two substitutions, A
36V and
R
495S, was obtained
once.
For each mutation, we used site-directed mutagenesis to recreate the
substitution in fresh plasmids that contained either
D or N at RT
position 211. In this way we confirmed the second-site
suppressor
status of the first two mutations and showed that the
A
36V
mutation was incidental, since suppression required only
the
R
495S substitution (Fig.
1D). Therefore, two different
substitutions
of the same R
495 residue can suppress the
transposition defect.
Both R
495 and K
463 are
located in the region that would be expected
to be within the Ty1 RNase
H domain. Our attempt to model either
R
495 or
K
463 within the context of the HIV-1 RNase H domain were
unrevealing, however, since both of these residues are present
in
nonconserved locations of the RNase H sequence (A. Gabriel
and S. Sarafianos, unpublished
observation).
We tested each recreated mutant version of Ty1 for histidine
prototrophy in an isogenic
rad52 strain to determine whether
the second-site suppressors actually restored transposition or,
alternatively, just restored the ability to synthesize cDNAs which
could recombine into the genome. As shown in Fig.
1G through L,
histidine prototroph formation for WT Ty1, as well as the
D
211N+R
495S
and the
D
211N+R
495G double mutants, was independent of
RAD52,
consistent with bona fide transposition. However,
histidine prototrophy
was
RAD52 dependent for
D
211N, D
211N+K
463R, and the RNase H
mutant,
consistent with cDNA
recombination.
To quantitatively compare the various Ty1 mutants, we next determined
the rate of transposition for each of the second-site
suppressors, in
the absence or presence of the D
211N mutation,
and compared
this to the rate of WT transposition under the same
conditions (Table
2). We used a
rad52 strain so that only transposition
events
would be observed. In this strain, the frequency of histidine
prototrophy for the D
211N mutant is so low (i.e., 40-fold
lower
than for the D
211N+K
463R double mutant)
that its transposition
rate could not be directly compared with that of
the other strains.
As shown in Table
2, both the
D
211N+R
495G and
D
211N+R
495S constructs
restored transposition
to ~5% of WT levels while the D
211N+K
463R
construct resulted in only 0.01% of WT levels of transposition,
in
agreement with our qualitative results (Fig.
1G to L). In the
context
of WT D
211, the R
495S and R
495G
mutations showed mild
to moderate defects in transposition (31 and
3.9% of WT) whereas
the K
463R substitution showed a slight
(2.5-fold) but significant
enhancement of transposition. These results
suggest that mutations
in R
495 or K
463 affect
different steps in the Ty1 replication
process.
The active-site mutant generates reduced levels of smaller
endogenous replication intermediates.
The endogenous
polymerization assay (Fig. 2) suggested that the D211N
mutant RT generates reduced levels of the msss intermediate. To
quantify this observation and to determine the presence and relative
abundance of other expected replication intermediates in WT and mutant
versions of Ty1 VLPs, we carried out a reiterative primer extension
analysis (46). As cartooned in Fig.
4, labeled strand-specific primers
will anneal to VLP-derived nucleic acids and be subsequently extended
only if particular intermediates are present. The intensity of
the resulting primer extension signal is proportionate to the abundance
of the intermediates. Because the 5' ends of minus-strand and
plus-strand cDNA intermediates are fixed by the IMT and PPT
respectively, we can identify discrete labeled extension products
distinct from potentially contaminating Ty1 genomic or plasmid DNA that
might also anneal to the primers.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
Reiterative primer extension analysis of Ty1 replication
intermediates. To determine the presence and abundance of
different-sized replication intermediates, 5'-end-labeled primers A
through E were annealed directly to VLPs (A) or nucleic acids extracted
from VLPs (B to E) and then repeatedly extended with Taq
polymerase. Since the absolute amounts of nucleic acids were not
comparable in each VLP preparation the relative intensities within each
panel cannot be directly compared. Further, the panels represent
different exposure times, to accentuate different points. The same
amounts of VLP nucleic acids, however, were used in each column,
regardless of exposure, so that the relative levels of each cDNA
template within a column can be compared.
|
|
We carried out primer extension reactions using WT

,
D
211N

, D
468S

, and
D
211N+R
495G-derived VLPs (Fig.
4). In addition
to the plus-strand primer in the R region (Fig.
4A), which will
detect
all minus-strand cDNAs, we used a plus-strand primer corresponding
to
the 5' end of U3, which will anneal and extend only if minus-strand
transfer has occurred (Fig.
4B). We used two additional plus-strand
primers 27 and 110 bases upstream of the PPT/U3 border (Fig.
4C
and D),
to determine if longer minus-strand products are synthesized.
Furthermore, we used a minus-strand primer corresponding to the
3' end
of U5 to detect the presence of plus-strand products (Fig.
4E). As
shown in Fig.
4, the different mutants showed distinct
patterns of
primer extension products. While high levels of all
extension products
were detected with WT VLPs, levels of extension
products for the
D
211N mutant were low throughout and progressively
diminished from those in panels A through D. This suggests that
fewer
and shorter in vivo cDNAs are made within D
211N VLPs. For
the RNase H mutant, the absolute level of msss product was similar
to
that of the WT, but the proportion of translocated products
was only
~3% of that of the WT (Table
3). The absolute level
of minus-strand
products was low for the D
211N+R
495G mutant,
but
the translocated products were long, similar to WT and the RNase
H
mutant. With the double mutant, we could also detect a low level
of
plus-strand intermediates (Fig.
4E).
To quantify the relative amount of minus-strand DNA derived from
different mutant RTs, we carried out reiterative primer extension
reactions using volumes of VLPs previously determined by Western
blot
analyses to contain equivalent amounts of RT protein. When
normalized
in this way, the amount of exogenous polymerase activity
was equivalent
for WT and D
211N VLPs (Table
3), but the amount
of
minus-strand cDNA present within the D
211N VLPs was
~20-fold
smaller than for either WT or the RNase H mutant.
Interestingly,
in the presence of the transposition-restoring
R
495G suppressor
mutation, the relative amount of
minus-strand cDNAs does not dramatically
change. These results do
not correlate with the in vitro polymerase
activities, indicating that
the D
211N mutant has an in vivo defect
in synthesizing
minus-strand cDNA. However, this is not the crucial
transposition
defect for the mutant enzyme, since the transposition-competent
double
mutant has similarly low levels of minus-strand
cDNA.
The observed patterns of intermediates provide clues to the basis for
the D
211N transposition defect. For the RNase H mutant,
the
small proportion of translocated products was expected, since
RNase H
activity has been shown in retroviral systems to be required
for strand
transfer (
14). For the D
211N and double
mutant, however,
the proportions of strand-transferred products were
intermediate
between those for the RNase H mutant and WT, i.e., ~19
and 55%
relative to WT. This implies that the D
211N mutant
enzyme retains
nonspecific RNase H activity. While we could not
accurately quantify
the relative levels of long
D
211N-derived minus-strand products
because of the low
signal-to-noise ratio (Fig.
4C and D), the
progressive decrease of the
primer extension signal in these lanes
suggests the possibility that
the mutant enzyme has a defect in
processive synthesis along its
natural RNA template. Finally,
the absence of plus-strand intermediates
in the D
211N VLPs, even
though some minus-strand synthesis
does proceed past the PPT (Fig.
4C and D), is noteworthy. The ability
of the double mutant to
transpose is correlated with the reappearance
of plus-strand products
(Fig.
4 panel E). From this we infer that one
crucial (and suppressible)
defect in the D
211N mutant is an
inability to generate and/or
extend the PPT primer that is required for
plus-strand
synthesis.
 |
DISCUSSION |
In this paper we demonstrate that the second aspartate of the
canonical YXDD box is not essential for Ty1 RT to carry out polymerization, a property which distinguishes this enzyme from HIV-1
RT. Given the universal occurrence of adjacent aspartates in
biochemically confirmed RTs, it has generally been assumed that these
residues, along with one additional invariant aspartate, are critical
for catalysis (17, 57). Our work indicates that this is
not entirely true. Replacement of Ty1 D211 with an
asparagine side chain leads to comparable levels of in vitro polymerase
activity, using two different primer-template substrates (Tables 1 and 3), as well as reduced but measurable in vivo polymerase activity (Fig.
2 and 4; Table 3). The loss of transposition, however, and our
observations that a D211E mutation does eliminate
polymerase activity, indicate that while not critical for catalysis,
this residue is intimately involved in the function of the enzyme. Other than for HIV-1, equivalent site-directed mutations of active-site aspartates have not previously been reported for any other RT source.
Given our finding, it will be important to experimentally verify
whether this aspartate is catalytically nonessential for other
retrovirus, retrotransposon, and retroelement RTs.
The alignment of aspartate or glutamate residues in the primary
sequences of all RNA- and DNA-dependent polymerases suggests a
universal role for negatively charged carboxylates in polymerization (17). The widely accepted "two-metal-ion mechanism"
for catalysis of polymerization by phosphoryl transfer proposes that
divalent metal ions function to position both the primer terminus and
the incoming nucleotide for nucleophilic attack, as well as to
stabilize the transition state (2). As determined in the
crystal structures of multiple polymerases, carboxylate side chains
contribute to coordinating the metal ions in the active site (22,
33, 35, 48, 58). However, structural comparison of the active
sites from four different ternary complexes of DNA polymerases with bound primer-template and nucleotide substrates (HIV-1 RT, T7 DNA
polymerase, Klentaq DNA polymerase, and DNA polymerase
), demonstrates that only two of the three conserved carboxylate residues
are superimposable in all four enzymes. These are the two residues
which directly coordinate metal ions (reviewed in reference
63). The positioning of the second aspartate in the YXDD
box of RTs, or its equivalent residue in other polymerases, is more
variable. Only in the most distantly related polymerase
are all
three carboxylate residues clearly seen directly coordinating metals in
the ternary complex (58). The fact that only two
aspartates are structurally conserved in polymerase active sites has
led Steitz to conclude that only two of the three aspartates are actual metal binding residues (68).
Further evidence for the flexibility of the third active-site
carboxylate in polymerases comes from phylogenetic and site-directed mutagenesis studies of polymerases other than RTs. In sequence alignments of DNA-directed RNA polymerases, no carboxylates equivalent to the second aspartate in motif C are present (17).
Several functional polymerases from minus-strand RNA viruses, including Sendai virus, measles virus, rabies virus, and vesicular stomatitis virus (VSV), encode DN rather than DD within their motifs C (reviewed in reference 60). Substitution of the VSV polymerase DN
with DD results in an enzyme with reduced but observable polymerase activity (67). For the equivalent "CGDD" box in
hepatitis C virus, site-directed mutation to either CGDN or CGDE
results in enzymes with ~8% of the WT in vitro polymerase activity
(50). Thus, for a retrotransposon RT, as well as several
distantly related viral RNA-dependent RNA polymerases, the second D in
motif C allows limited side chain replacement. Given the belief that
RTs are derived from RNA-dependent RNA polymerases, these results
suggest that the active-site geometry of retrotransposon polymerases
share a flexibility with this class of viral enzymes that may have been lost in the HIV-1 polymerase.
An alternative interpretation of the polymerase activity associated
with the D211N mutant form of Ty1 RT is that this residue is particularly prone to hydrolytic deamidation, thereby recreating the
wild-type enzyme. Slow spontaneous asparagine deamidation does occur in
many proteins as a function of aging, e.g., lens crystallins
(3). More interestingly, rapid reversion of a mutant active-site asparagine to WT aspartate has been observed for two dehalogenases, possibly catalyzed by the presence of the reaction product (62, 75). However, it is unlikely that this can
explain our data. In particular, the specific activities of the mutant and WT enzymes are similar (Table 3), implying that most of the mutant
protein would have to be reverted to the WT form. In that case, the
mutant Ty1 element should be competent for transposition. Instead, the
mutant is completely dead for transposition, consistent with the
mutated side chain being present in the enzyme, blocking one or more
step in the transposition process. The presence of different
second-site suppressor mutants, which have varied effects on restoring
cDNA recombination or transposition, implies complex functional
interactions between the active-site mutation and other domains within
the enzyme, rather than an effect on deamidation of asparagine to
aspartate. Further, D211N VLPs show a distinctive pattern
of replication intermediates (Fig. 4), as expected for an enzyme with
multiple defects in the polymerization process, rather than simply a
reduced level of WT enzyme. Thus, while definitive proof of deamidation
will require direct sequence analysis of a purified form of the mutant
Ty1 RT, such an explanation is inconsistent with our combined
biochemical and genetic data.
The D211N mutant enzyme cannot direct transposition,
despite the observed in vitro and in vivo polymerase activity. Our
finding that both of the intragenic second-site suppressor mutations
map to the RNase H domain raises the possibility that either the
original mutation in the polymerase active site causes a defect in
RNase H function or the substitutions in the RNase H domain partially restore some defect in polymerase function. A recent study suggests that the Ty1 RT and RNase H active sites are separated by a 14-nt RNA-DNA heteroduplex (74). Work with retroviral systems
has shown that the polymerase and RNase H domains of RTs are
structurally distinct but interrelated entities. Active isolated RNase
H domains can be expressed (26, 64), and pairs of
defective MuLV RTs, with active-site mutations in polymerase and RNase
H, are capable of in vivo complementation (70). On the
other hand, studies have identified mutations in one domain that affect
only the activity of the other domain (10, 30, 56, 69).
These results have led to the intriguing idea that mutations in one
domain can exert their effects over long distances by altering the
positioning of the nucleic acid duplex between the active sites, which
consequently affect the precise orientation of substrate at the active
sites (10, 11, 30).
We have no direct assay to measure Ty1 VLP-associated RNase H nuclease
activity, so we can make only indirect inferences about its function in
the mutant enzyme. The D211N mutant does not behave like
the D468S RNase H active-site mutant during strand
transfer, suggesting that nonspecific RNA hydrolysis activity is
present in the D211N mutant. The essential replication
defect of the D211N mutant could, however, be an indirect
consequence of positional changes of the RNA-DNA hybrid on more subtle
aspects of RNase H function. For example, the D211N mutant
is incapable of plus-strand synthesis, but this defect can be partially
suppressed by a second mutation in the RNase H domain at
R495. Initiation of plus-strand synthesis requires several
specific events. First, minus-strand cDNA synthesis must proceed past
the PPT, to generate an RNA-DNA hybrid of the region. Second, RNase H
must recognize the PPT and make specific cleavages upstream and
downstream of this sequence to generate the PPT primer. Finally, the
polymerase active site must specifically bind the PPT primer and
minus-strand cDNA template, to initiate plus-strand synthesis. Our data
on D211N replication intermediates demonstrate a low level
of minus-strand extension beyond the PPT. Therefore we propose that the
D211N mutation interferes either with RNase H correctly
recognizing and cleaving the PPT substrate or with the polymerase
recognizing and extending the PPT primer once it has been generated.
According to this scenario, the R495 suppressor mutation
causes a reorientation of the nucleic acid substrates that either
allows PPT to be generated or partially restores the primer recognition
or utilization function of the polymerase.
An additional D211N defect is its significantly lower level
of msss synthesis, which is not corrected by the R495G
suppressor mutation. The reduced level of msss is not due simply to
reduced processive synthesis, since reiterative primer extension using a plus-strand primer in U5, much closer to the IMT primer, gave the
same result as in Fig. 4A (data not shown). Further, the
D211N+R495G double mutant appears capable of
synthesizing long minus-strand products but still has reduced levels of
msss. While we can only speculate about the nature of this minus-strand
defect, plausible explanations include decreased RT-mediated packaging
of the tRNA primer (59), decreased formation of the
initiation complex consisting of a tRNA primer annealed to the RNA
template in the enzyme active site (1, 28), and even a
defect in the chemistry of polymerization initiation, distinct from
elongation, which specifically involves interactions between the enzyme
and the tRNA primer (37, 43). Distinguishing these
possibilities is amenable to existing experimental approaches and is an
area of future interest.
What is the mechanistic significance of the functional aspartate
substitution in the Ty1 RT polymerase active site? Our findings suggest
that the Ty1 D211 side chain is positioned within the active site but that the negatively charged carboxylate of this residue
is not essential for the phosphoryl transfer reaction. If
D211 does retain a catalytic role, then the retrotransposon enzyme must be able to compensate for the side chain alteration. It is
possible that the asparagine can still stabilize the transition state,
position the primer end, or even coordinate a metal ion indirectly
through an intervening water molecule. Such an enzyme would probably
have significant alterations in its kinetic properties compared to WT.
Alternatively, the second D in the YXDD box of Ty1 RT may simply play
an important structural role without any direct catalytic function.
Using our current biochemical assays for VLP-associated polymerase
activity, it is impractical to carry out the thorough enzymological
studies to distinguish these possibilities. However, a recombinant form
of Ty1 RT has recently been reported (74). Future use of
this recombinant enzyme should allow us to compare the detailed
enzymatic properties of the WT and mutant Ty1 enzymes. Ultimately,
understanding the basis for our observations will require analysis of
the crystal structure of retrotransposon RTs. With the availability of
an active recombinant Ty1 enzyme, this goal may now be feasible.
 |
ACKNOWLEDGMENTS |
This work was funded in part by the Charles and Johanna Busch
Endowment, the Lucille P. Markey Charitable Trust, and National Institutes of Health grants AI00803 and AI39201.
We thank D. Garfinkel for providing polyclonal antisera TyB8; J. Curcio for providing plasmids; D. Voytas for sharing unpublished protocols; A. Gill, E. Mules, R. Robichaud, and Z. Liu for giving technical assistance; E. Arnold, S. Brill, M. Gartenberg, M. Georgiadis, S. Goff, S. Sarafianos, N. Uzun, and members of the Gabriel
laboratory for helpful discussions; and R. Steward, M. Georgiadis, and
S. Sarafianos for manuscript review. Special thanks go to Jef Boeke, in
whose laboratory this work was initiated.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Biology and Biochemistry, Rutgers University, CABM 306, 679 Hoes Lane, Piscataway, NJ 08854. Phone: (732) 235-5097. Fax: (732) 235-4880. E-mail: gabriel{at}cabm.rutgers.edu.
Dedicated to the memory of Esther M. Gabriel.
 |
REFERENCES |
| 1.
|
Arts, E. J.,
M. Ghosh,
P. S. Jacques,
B. Ehresmann, and S. F. Le Grice.
1996.
Restoration of tRNA -primed ( )-strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs. Implications for retroviral replication.
J. Biol. Chem.
271:9054-9061[Abstract/Free Full Text].
|
| 2.
|
Beese, L. S., and T. A. Steitz.
1991.
Structural basis for 3'-5' exonuclease activity of Escherichia coli DNA polymerase 1: a two-metal-ion mechanism.
EMBO J.
10:25-33[Medline].
|
| 3.
|
Bloemendal, H.,
A. J. Berns,
F. van der Ouderaa, and W. W. de Jong.
1972.
Evidence for a "non-genetic" origin of the A1 chains of alpha-crystallin.
Exp Eye Res.
14:80-81[CrossRef][Medline].
|
| 4.
|
Boeke, J. D.,
D. J. Garfinkel,
C. A. Styles, and G. R. Fink.
1985.
Ty elements transpose through an RNA intermediate.
Cell
40:491-500[CrossRef][Medline].
|
| 5.
|
Boeke, J. D.,
F. Lacroute, and G. R. Fink.
1984.
A positive selection for mutants lacking orotidine 5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance.
Mol. Gen. Genet.
197:345-346[CrossRef][Medline].
|
| 6.
|
Boeke, J. D.,
C. A. Styles, and G. R. Fink.
1986.
Saccharomyces cerevisiae SPT3 gene is required for transposition and transpositional recombination of chromosomal Ty elements.
Mol. Cell. Biol.
6:3575-3581[Abstract/Free Full Text].
|
| 7.
|
Boeke, J. D.,
H. Xu, and G. R. Fink.
1988.
A general method for the chromosomal amplification of genes in yeast.
Science
239:280-282[Abstract/Free Full Text].
|
| 8.
|
Boer, P. H., and M. W. Gray.
1988.
Genes encoding a subunit of respiratory NADH dehydrogenase (ND1) and a reverse transcriptase-like protein (RTL) are linked to ribosomal RNA gene pieces in Chlamydomonas reinhardtii mitochondrial DNA.
EMBO J.
7:3501-3508[Medline].
|
| 9.
|
Bowen, N. J., and J. F. McDonald.
1999.
Genomic analysis of Caenorhabditis elegans reveals ancient families of retroviral-like elements.
Genome Res.
9:924-935[Abstract/Free Full Text].
|
| 10.
|
Boyer, P. L.,
A. L. Ferris,
P. Clark,
J. Whitmer,
P. Frank,
C. Tantillo,
E. Arnold, and S. H. Hughes.
1994.
Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase.
J. Mol. Biol.
243:472-483[CrossRef][Medline].
|
| 11.
|
Boyer, P. L.,
A. L. Ferris, and S. H. Hughes.
1992.
Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.
J. Virol.
66:1031-1039[Abstract/Free Full Text].
|
| 12.
|
Braiterman, L. T.,
G. M. Monokian,
D. J. Eichinger,
S. L. Merbs,
A. Gabriel, and J. D. Boeke.
1994.
In-frame linker insertion mutagenesis of yeast transposon Ty1: phenotypic analysis.
Gene
139:19-26[CrossRef][Medline].
|
| 13.
|
Chapman, K. B.,
A. S. Byström, and J. D. Boeke.
1992.
Initiator methionine tRNA is essential for Ty1 transposition in yeast.
Proc. Natl. Acad. Sci. USA
89:3236-3240[Abstract/Free Full Text].
|
| 14.
|
Coffin, J. M.,
S. H. Hughes, and H. E. Varmus (ed.).
1997.
Retroviruses.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 15.
|
Curcio, M. J., and D. J. Garfinkel.
1994.
Heterogeneous functional Ty1 elements are abundant in the Saccharomyces cerevisiae genome.
Genetics
136:1245-1259[Abstract].
|
| 16.
|
Curcio, M. J., and D. J. Garfinkel.
1991.
Single-step selection for Ty1 element retrotransposition.
Proc. Natl. Acad. Sci. USA
88:936-940[Abstract/Free Full Text].
|
| 17.
|
Delarue, M.,
O. Poch,
N. Tordo,
D. Moras, and P. Argos.
1990.
An attempt to unify the structure of polymerases.
Protein Eng.
3:461-467[Abstract/Free Full Text].
|
| 18.
|
Derr, L. K., and J. N. Strathern.
1993.
A role for reverse transcripts in gene conversion.
Nature
361:170-173[CrossRef][Medline].
|
| 19.
|
Derr, L. K.,
J. N. Strathern, and D. J. Garfinkel.
1991.
RNA-mediated recombination in S. cerevisiae.
Cell
67:355-364[CrossRef][Medline].
|
| 20.
|
Dombroski, B. A.,
Q. Feng,
S. L. Mathias,
D. M. Sassaman,
A. F. Scott,
H. H. Kazazian, and J. D. Boeke.
1994.
An in vivo assay for the reverse transcriptase of human retrotransposon L1 in Saccharomyces cerevisiae.
Mol. Cell. Biol.
14:4485-4492[Abstract/Free Full Text].
|
| 21.
|
Doolittle, R. F.,
D.-F. Feng,
M. S. Johnson, and M. A. McClure.
1989.
Origins and evolutionary relationships of retroviruses.
Q. Rev. Biol.
64:1-29[CrossRef][Medline].
|
| 22.
|
Doublie, S.,
S. Tabor,
A. M. Long,
C. C. Richardson, and T. Ellenberger.
1998.
Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 Å resolution.
Nature
391:251-258[CrossRef][Medline].
|
| 23.
|
Drake, J. W.
1991.
A constant rate of spontaneous mutation in DNA-based microbes.
Proc. Natl. Acad. Sci. USA
88:7160-7164[Abstract/Free Full Text].
|
| 24.
|
Eichinger, D. J., and J. D. Boeke.
1988.
The DNA intermediate in yeast Ty1 element transposition copurifies with virus-like particles: cell-free Ty1 transposition.
Cell
54:955-966[CrossRef][Medline].
|
| 25.
|
Eickbush, T. H.
1997.
Telomerase and retrotransposons: which came first?
Science
277:911-912[Free Full Text].
|
| 26.
|
Evans, D. B.,
K. Brawn,
M. R. Deibel, Jr.,
W. G. Tarpley, and S. K. Sharma.
1991.
A recombinant ribonuclease H domain of HIV-1 reverse transcriptase that is enzymatically active.
J. Biol. Chem.
266:20583-20585[Abstract/Free Full Text].
|
| 27.
|
Felder, H.,
A. Herzceg,
Y. de Chastonay,
P. Aeby,
H. Tobler, and F. Muller.
1994.
Tas, a retrotransposon from the parasitic nematode Ascaris lumbricoides.
Gene
149:219-225[CrossRef][Medline].
|
| 28.
|
Friant, S.,
T. Heyman,
A. S. Bystrom,
M. Wilhelm, and F. X. Wilhelm.
1998.
Interactions between Ty1 retrotransposon RNA and the T and D regions of the tRNA primer are required for initiation of reverse transcription in vivo.
Mol. Cell. Biol.
18:799-806[Abstract/Free Full Text].
|
| 29.
|
Gabriel, A., and J. D. Boeke.
1991.
Reverse transcriptase encoded by a retrotransposon from the trypanosomatid Crithidia fasciculata.
Proc. Natl. Acad. Sci. USA
88:9794-9798[Abstract/Free Full Text].
|
| 30.
|
Gao, H. Q.,
P. L. Boyer,
E. Arnold, and S. H. Hughes.
1998.
Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase.
J. Mol. Biol.
277:559-572[CrossRef][Medline].
|
| 31.
|
Garfinkel, D. J.,
J. D. Boeke, and G. R. Fink.
1985.
Ty element transposition: reverse transcriptase and virus-like particles.
Cell
42:507-517[CrossRef][Medline].
|
| 32.
|
Garfinkel, D. J.,
A. Hedge,
S. D. Youngren, and T. D. Copeland.
1991.
Proteolytic processing of pol-TYB proteins from the yeast retrotransposon Ty1.
J. Virol.
65:4573-4581[Abstract/Free Full Text].
|
| 33.
|
Georgiadis, M. M.,
S. M. Jensen,
C. M. Ogata,
A. Telesnitsky,
S. P. Goff, and W. A. Hendrickson.
1995.
Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase.
Structure
3:879-892.
|
| 34.
|
Hoffman, C. S., and F. Winston.
1987.
A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli.
Gene
57:267-272[CrossRef][Medline].
|
| 35.
|
Huang, H.,
R. Chopra,
G. L. Verdine, and S. C. Harrison.
1998.
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.
Science
282:1669-1675[Abstract/Free Full Text].
|
| 36.
|
Inouye, M., and S. Inouye.
1991.
Retroelements in bacteria.
Trends Biochem. Sci.
16:18-21[CrossRef][Medline].
|
| 37.
|
Isel, C.,
J. M. Lanchy,
S. F. Le Grice,
C. Ehresmann,
B. Ehresmann, and R. Marquet.
1996.
Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA .
EMBO J.
15:917-924[Medline].
|
| 38.
|
Jacobo-Molina, A.,
J. Ding,
R. G. Nanni,
A. D. J. Clark,
X. Lu,
R. L. Williams,
G. Kamer,
A. L. Ferris,
P. Clark,
A. Hizi,
S. H. Hughes, and E. Arnold.
1993.
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA.
Proc. Natl. Acad. Sci. USA
90:6320-6324[Abstract/Free Full Text].
|
| 39.
|
Kaushik, N.,
N. Rege,
P. N. Yadav,
S. G. Sarafianos,
M. J. Modak, and V. N. Pandey.
1996.
Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase.
Biochemistry
35:11536-11546[CrossRef][Medline].
|
| 40.
|
Kim, J. M.,
S. Vanguri,
J. D. Boeke,
A. Gabriel, and D. F. Voytas.
1998.
Transposable elements and genome organization: a comprehensive survey of retrotransposons revealed by the Saccharomyces cerevisiae genome sequence.
Genome Res.
8:464-478[Abstract/Free Full Text].
|
| 41.
|
Kohlstaedt, L. A.,
J. Wang,
J. M. Friedman,
P. A. Rice, and T. A. Steitz.
1992.
Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor.
Science
256:1783-1790[Abstract/Free Full Text].
|
| 42.
|
Kunkel, T. A.
1985.
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Proc. Natl. Acad. Sci. USA
82:488-492[Abstract/Free Full Text].
|
| 43.
|
Lanchy, J. M.,
G. Keith,
S. F. Le Grice,
B. Ehresmann,
C. Ehresmann, and R. Marquet.
1998.
Contacts between reverse transcriptase and the primer strand govern the transition from initiation to elongation of HIV-1 reverse transcription.
J. Biol. Chem.
273:24425-24432[Abstract/Free Full Text].
|
| 44.
|
Larder, B. A.,
S. D. Kemp, and D. J. M. Purifoy.
1989.
Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.
Proc. Natl. Acad. Sci. USA
86:4803-4807[Abstract/Free Full Text].
|
| 45.
|
Larder, B. A.,
D. J. Purifoy,
K. L. Powell, and G. Darby.
1987.
Site-specific mutagenesis of AIDS virus reverse transcriptase.
Nature
327:716-717[CrossRef][Medline].
|
| 46.
|
Lauermann, V., and J. D. Boeke.
1997.
Plus strand strong-stop DNA transfer in yeast Ty retrotransposons.
EMBO J.
16:6603-6612[CrossRef][Medline].
|
| 47.
|
Le Grice, S. F. J.,
T. Naas,
B. Wohlgensinger, and O. Schatz.
1991.
Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase.
EMBO J.
10:3905-3911[Medline].
|
| 48.
|
Li, Y.,
S. Korolev, and G. Waksman.
1998.
Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase I: structural basis for nucleotide incorporation.
EMBO J.
17:7514-7525[CrossRef][Medline].
|
| 49.
|
Lingner, J.,
T. R. Hughes,
M. M. Shevchenko,
V. Lundblad, and T. R. Cech.
1997.
Reverse transcriptase motifs in the catalytic subunit of telomerase.
Science
276:561-567[Abstract/Free Full Text].
|
| 50.
|
Lohmann, V.,
F. Korner,
U. Herian, and R. Bartenschlager.
1997.
Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity.
J. Virol.
71:8416-8428[Abstract].
|
| 51.
|
Melamed, C.,
Y. Nevo, and M. Kupiec.
1992.
Involvement of cDNA in homologous recombination between Ty elements in Saccharomyces cerevisiae.
Mol. Cell. Biol.
12:1613-1620[Abstract/Free Full Text].
|
| 52.
|
Moore, S. P., and D. J. Garfinkel.
1994.
Expression and partial purification of enzymatically active recombinant Ty1 integrase in Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
91:1843-1847[Abstract/Free Full Text].
|
| 53.
|
Mules, E. H.,
O. Uzun, and A. Gabriel.
1998.
Replication errors during in vivo Ty1 transposition are linked to heterogeneous RNase H cleavage sites.
Mol. Cell. Biol.
18:1094-1104[Abstract/Free Full Text].
|
| 54.
|
Müller, F.,
W. Laufer,
U. Pott, and M. Ciriacy.
1991.
Characterization of products of Ty1-mediated reverse transcription in Saccharomyces cerevisiae.
Mol. Gen. Genet.
226:145-153[CrossRef][Medline].
|
| 55.
|
Nakamura, T. M., and T. R. Cech.
1998.
Reversing time: origin of telomerase.
Cell
92:587-590[Medline].
|
| 56.
|
Palaniappan, C.,
M. Wisniewski,
P. S. Jacques,
S. F. LeGrice,
P. J. Fay, and R. A. Bambara.
1997.
Mutations within the primer grip region of HIV-1 reverse transcriptase result in loss of RNase H function.
J. Biol. Chem.
272:11157-11164[Abstract/Free Full Text].
|
| 57.
|
Patel, P. H.,
A. Jacobo-Molina,
J. Ding,
C. Tantillo,
A. D. Clark,
R. Raag,
R. G. Nanni,
S. H. Hughes, and E. Arnold.
1995.
Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.
Biochemistry
34:5351-5365[CrossRef][Medline].
|
| 58.
|
Pelletier, H.,
M. R. Sawaya,
A. Kumar,
S. H. Wilson, and J. Kraut.
1994.
Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP.
Science
264:1891-1903[Abstract/Free Full Text].
|
| 59.
|
Peters, G. G., and J. Hu.
1980.
Reverse transcriptase as the major determinant for selective packaging of tRNAs into avian sarcoma virus particles.
J. Virol.
36:692-670[Abstract/Free Full Text].
|
| 60.
|
Poch, O.,
I. Sauvaget,
M. Delarue, and N. Tordo.
1989.
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
EMBO J.
8:3867-3874[Medline].
|
| 61.
|
Pochart, P.,
B. Agoutin,
S. Rousset,
R. Chanet,
V. Doroszkiewicz, and T. Heyman.
1993.
Biochemical and electron microscope analyses of the DNA reverse transcripts present in the virus-like particles of the yeast transposon Ty1. Identification of a second origin of Ty1 DNA plus strand synthesis.
Nucleic Acids Res.
21:3513-3520[Abstract/Free Full Text].
|
| 62.
|
Pries, F.,
J. Kingma, and D. B. Janssen.
1995.
Activation of an Asp-124 Asn mutant of haloalkane dehalogenase by hydrolytic deamidation of asparagine.
FEBS Lett.
358:171-174[CrossRef][Medline].
|
| 63.
|
Sarafianos, S. G.,
K. Das,
J. Ding,
P. L. Boyer,
S. H. Hughes, and E. Arnold.
1999.
Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site.
Chem. Biol.
6:R137-R146[CrossRef][Medline].
|
| 64.
|
Schultz, S. J., and J. J. Champoux.
1996.
RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity.
J. Virol.
70:8630-8638[Abstract].
|
| 65.
|
Sharon, G.,
T. J. Burkett, and D. J. Garfinkel.
1994.
Efficient homologous recombination of Ty1 element cDNA when integration is blocked.
Mol. Cell. Biol.
14:6540-6551[Abstract/Free Full Text].
|
| 66.
|
Sherman, F.,
G. R. Fink, and J. B. Hicks.
1986.
Methods in yeast genetics: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 67.
|
Sleat, D. E., and A. K. Banerjee.
1993.
Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase.
J. Virol.
67:1334-1339[Abstract/Free Full Text].
|
| 68.
|
Steitz, T. A.
1999.
DNA polymerases: structural diversity and common mechanisms.
J. Biol. Chem.
274:17395-17398[Free Full Text].
|
| 69.
|
Telesnitsky, A., and S. P. Goff.
1993.
RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.
Proc. Natl. Acad. Sci. USA
90:1276-1280[Abstract/Free Full Text].
|
| 70.
|
Telesnitsky, A., and S. P. Goff.
1993.
Two defective forms of reverse transcriptase can complement to restore retroviral infectivity.
EMBO J.
12:4433-4438[Medline].
|
| 71.
|
Teng, S.-C.,
B. Kim, and A. Gabriel.
1996.
Retrotransposon reverse transcriptase-mediated repair of chromosomal breaks.
Nature
383:641-644[CrossRef][Medline].
|
| 72.
|
Toh, H.,
H. Hayashida, and T. Miyata.
1983.
Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus.
Nature
305:827-829[CrossRef][Medline].
|
| 73.
|
Wang, H., and A. M. Lambowitz.
1993.
The Mauriceville plasmid reverse transcriptase can initiate cDNA synthesis de novo and may be related to reverse transcriptase and DNA polymerase progenitor.
Cell
75:1071-1081[CrossRef][Medline].
|
| 74.
|
Wilhelm, M.,
M. Boutabout, and F.-X. Wilhelm.
2000.
Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.
Biochem. J.
348:337-342.
|
| 75.
|
Xiang, H.,
J. Dong,
P. R. Carey, and D. Dunaway-Mariano.
1999.
Product catalyzes the deamidation of D145N dehalogenase to produce the wild-type enzyme.
Biochemistry
38:4207-4213[CrossRef][Medline].
|
| 76.
|
Xiong, Y., and T. H. Eickbush.
1990.
Origin and evolution of retroelements based on their reverse transcriptase sequences.
EMBO J.
9:3353-3362[Medline].
|
| 77.
|
Zhou, Y.,
X. Zhang, and R. H. Ebright.
1991.
Random mutagenesis of gene-sized DNA molecules by use of PCR with Taq DNA polymerase.
Nucleic Acids Res.
19:6052[Free Full Text].
|
| 78.
|
Zimmerly, S.,
H. Guo,
P. S. Perlman, and A. M. Lambowitz.
1995.
Group II intron mobility occurs by target DNA-primed reverse transcription.
Cell
82:545-554[CrossRef][Medline].
|
Journal of Virology, July 2001, p. 6337-6347, Vol. 75, No. 14
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.14.6337-6347.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wilhelm, M., Wilhelm, F.-X.
(2006). Cooperation between Reverse Transcriptase and Integrase during Reverse Transcription and Formation of the Preintegrative Complex of Ty1.. Eukaryot Cell
5: 1760-1769
[Abstract]
[Full Text]
-
COOMBES, C. E., BOEKE, J. D.
(2005). An evaluation of detection methods for large lariat RNAs. RNA
11: 323-331
[Abstract]
[Full Text]
-
BOLTON, E. C., COOMBES, C., EBY, Y., CARDELL, M., BOEKE, J. D.
(2005). Identification and characterization of critical cis-acting sequences within the yeast Ty1 retrotransposon. RNA
11: 308-322
[Abstract]
[Full Text]
-
Bibillo, A., Lener, D., Klarmann, G. J., Le Grice, S. F. J.
(2005). Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase. Nucleic Acids Res
33: 171-181
[Abstract]
[Full Text]
-
Pandey, M., Patel, S., Gabriel, A.
(2004). Insights into the Role of an Active Site Aspartate in Ty1 Reverse Transcriptase Polymerization. J. Biol. Chem.
279: 47840-47848
[Abstract]
[Full Text]
-
Wilhelm, F.-X., Wilhelm, M., Gabriel, A.
(2003). Extension and Cleavage of the Polypurine Tract Plus-strand Primer by Ty1 Reverse Transcriptase. J. Biol. Chem.
278: 47678-47684
[Abstract]
[Full Text]
-
Bowen, N. J., Jordan, I. K., Epstein, J. A., Wood, V., Levin, H. L.
(2003). Retrotransposons and Their Recognition of pol II Promoters: A Comprehensive Survey of the Transposable Elements From the Complete Genome Sequence of Schizosaccharomyces pombe. Genome Res
13: 1984-1997
[Abstract]
[Full Text]
-
Lener, D., Budihas, S. R., Le Grice, S. F. J.
(2002). Mutating Conserved Residues in the Ribonuclease H Domain of Ty3 Reverse Transcriptase Affects Specialized Cleavage Events. J. Biol. Chem.
277: 26486-26495
[Abstract]
[Full Text]
-
Wilhelm, M., Uzun, O., Mules, E. H., Gabriel, A., Wilhelm, F.-X.
(2001). Polypurine Tract Formation by Ty1 RNase H. J. Biol. Chem.
276: 47695-47701
[Abstract]
[Full Text]